Latest Radiobiology Stories
BOSTON, Oct. 24, 2012 /PRNewswire/ -- At the 54(th) Annual Meeting of the American Society for Radiation Oncology (ASTRO), October 28-31 in Boston, Elekta (booth #5067) will highlight its Agility(TM)* 160-leaf multi-leaf collimator (MLC), which has been shipped to more than 20 countries worldwide in the last six months. Agility, a groundbreaking new design of the MLC, features leaf speeds that are twice as fast as conventional beam-shaping devices, and offers a new level of...
PITTSBURGH, Oct. 23, 2012 /PRNewswire/ -- The team of dosimetrists and physicists at D3 Oncology Solutions (D3), an affiliate of UPMC and UPMC CancerCenter, recently surpassed significant milestones: completing their 30,000(th) advanced treatment plan and commissioning their 100(th) linear accelerator. (Logo: http://photos.prnewswire.com/prnh/20110301/NE55044LOGO ) "These milestones are significant for us because they reflect the continued confidence of our customers in the quality...
ATLANTA, Oct. 22, 2012 /PRNewswire/ -- In the last six months, cancer clinics in 21 countries have accepted delivery of Elekta's Agility(TM)*, an innovative, ground-breaking 160-leaf multi-leaf collimator (MLC) that utilizes industry-leading technology to provide faster, more accurate, and more versatile radiation therapy for individuals with cancer. Agility was recently introduced at Radboud University Nijmegen Medical Center (Nijmegen, Netherlands), where a 48-year-old woman,...
Michael Harper for redOrbit.com – Your Universe Online It’s a debate nearly as old as cell phones themselves: Whether these mobile devices can cause brain tumors or if they pose no direct danger to humans. While study after study has been performed which proves and disproves both sides, an Italian court has taken it upon themselves to make an official ruling on the matter. According to Reuters, the Supreme Court of Italy has upheld a ruling which said one business executive’s...
SUNNYVALE, Calif., Oct. 19, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today announced that it will report results for its first quarter of fiscal 2013, ended September 30, 2012 on Wednesday, November 7, 2012 after the market closes. A conference call to review the results will begin at 2:00 p.m. PST/5:00 p.m. EST and will be hosted by Joshua H. Levine, president and chief executive officer and Derek Bertocci, senior vice...
Berkeley Lab research could lead to new ways to ID women who have higher risk of breast cancer from low-dose radiation Scientists from the U.S. Department of Energy’s Lawrence Berkeley National Laboratory (Berkeley Lab) have identified tissue mechanisms that may influence a woman’s susceptibility or resistance to breast cancer after exposure to low-dose ionizing radiation, such as the levels used in full-body CT scans and radiotherapy. The research could lead to new ways to identify...
AUSTIN, Texas, Oct. 17, 2012 /PRNewswire/ -- 1-800-Oncologist, Inc. announced today that Optim Oncology, Inc. has joined its national network of Digital Oncologists(TM). Optim Oncology, a leading provider of cancer care and radiation therapy services, is the largest freestanding oncology practice in Oklahoma with seven locations throughout the state. As a 1-800-Oncologist network affiliate, Optim Oncology has integrated a 'Total Patient Engagement' solution to streamline existing and...
A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D., from the University of Tennessee Health Science Center and Baylor College of Medicine, show that application of this drug, starting 24 hours after radiation exposure, increases survival in animal models by three-fold compared to placebo. Their work, which is...
Children who undergo brain radiation therapy run a significant risk of suffering from permanent neurocognitive adverse effects. These adverse effects are due to the fact that the radiation often encounters healthy tissue. This reduces the formation of new cells, particularly in the hippocampus – the part of the brain involved in memory and learning. Researchers at the University of Gothenburg's Sahlgrenska Academy have used a model study to test newer radiation therapy techniques which...
TAICHUNG, Taiwan, Oct. 15, 2012 /PRNewswire/ -- Doctors at the Cheng Ching General Hospital here have begun treating liver cancer with image-guided radiosurgery using a new TrueBeam(TM) STx system from Varian Medical Systems (NYSE:VAR). The hospital has developed a program for treating hepatocellular carcinoma (HCC), a common type of liver cancer that is widespread in Asia. "With TrueBeam STx, we can generate images of the tumor during the treatment, and use them to adapt the...
Latest Radiobiology Reference Libraries
Nuclear fallout, or just simply fallout, known also as Black Rain, is the residual radioactive material that is propelled into the upper atmosphere after a nuclear black or a nuclear reaction that is conducted in an unshielded facility. It is so called because it "fall out" of the sky after the explosion and the shock wave have passed. It most commonly refers to the radioactive dust and ash that is created when a nuclear weapon explodes, but such dust can also come from a damaged nuclear...
